SignatureFD
MBOT icon

SignatureFD’s Microbot Medical MBOT Stock Holding History

SignatureFD’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$22 Hold
18
– – ﹤0.01% 3523
2026
Q2 		$35 Hold
18
– – ﹤0.01% 3471
2026
Q1 		$43 Hold
18
– – ﹤0.01% 3419
2025
Q4 		$36 Hold
18
– – ﹤0.01% 3347
2025
Q3 		$55 Buy
+18
New +$56 ﹤0.01% 3332

Other funds holding MBOT

Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return
Integrity Alliance
Integrity Alliance Urbandale, Iowa $3.28B AUM 15.79% 1-Year Est. Return
Lazari Capital Management
Lazari Capital Management Woodland Hills, California $339M AUM 25.58% 1-Year Est. Return
Beacon Capital Management LLC (Tennessee)
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $716M AUM 16.7% 1-Year Est. Return
OpenArc Corporate Advisory
OpenArc Corporate Advisory Atlanta, Georgia $8.86B AUM 19.31% 1-Year Est. Return
BFSG LLC
BFSG LLC Irvine, California $1.14B AUM 21.04% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
Asset Planning Inc
Asset Planning Inc Cypress, California $152M AUM 19.47% 1-Year Est. Return
Guardian Partners
Guardian Partners Toronto, Canada $1.13B AUM 28.37% 1-Year Est. Return
Leonteq Securities AG
Leonteq Securities AG Zurich, Switzerland $2.44B AUM 50.17% 1-Year Est. Return

SignatureFD's MBOT Position: Q3 2026 in Review

SignatureFD held its Microbot Medical (MBOT) position steady in Q3 2026 at 18 shares worth $22. The position accounts for ﹤0.01% of the portfolio, ranked #3523.

SignatureFD first reported a position in MBOT in Q3 2025 and has held it in 5 quarters since. The position peaked at $55 in Q3 2025. 16 funds tracked by Wall St. Rank hold MBOT as of Q3 2026.

  • SignatureFD held 18 shares of Microbot Medical worth $22 as of Q3 2026.
  • SignatureFD left its Microbot Medical share count unchanged in Q3 2026.
  • Microbot Medical made up ﹤0.01% of SignatureFD's portfolio in Q3 2026, its #3523 holding.
  • SignatureFD first reported a position in Microbot Medical in Q3 2025 and has held it in 5 quarters since.
  • SignatureFD's Microbot Medical position peaked at $55 in Q3 2025.
  • 16 funds tracked by Wall St. Rank held Microbot Medical as of Q3 2026.

Based on SignatureFD's 13F filing for Q3 2026, filed 23 Oct 2026.